In vivo-molecular and morphological imaging of somatostatin receptors by real time confocal mini-microscopy

Authors:

Abstract
Objective: Expression of somatostatin-receptors (sstr) in neuroendocrine tumors represent the molecular basis for various clinical diagnostic and therapeutic applications. The aim of the current study was to evaluate in-vivo molecular imaging of sstr using real time confocal mini microscopy (CMM) in conjunction with fluorescent labelled octreotate. Methods: CMM was performed using a small rigid probe with an outer diameter of 7mm and an integrated single line laser (488 nm). Fluorescein labeled octreotate (OcF) was synthesized via Fmoc solid phase peptide synthesis. For in-vitro evaluation of OcF, ssstr-expressing exocrine rat pancreatic cancer cells (AR42J) were used. For in-vivo experiments, confocal images of rat pancreas and solid sstr-expressing tumors, induced after subcutaneous injection of AR42J cells into nude mice, were collected following bolus intravenous injection of OcF (15µg/g). Results: Incubation of AR42J cells with OcF showed a time- and dose dependent staining of the cells. Binding specificity could be demonstrated by adding excess amount of unlabeled octreotide, showing an almost complete displacement of OcF. After systemic application to rats, an internalization and homogenous cytoplasmic distribution into pancreatic islet cells was recorded after an incubation time of 30–45 minutes, representing sstr-positive islet cells as correlated with the histological examination. Molecular targeting of sstr-positive tumor-cells in-vivo was demonstrated after application of OcF to tumor expressing nude mice. Tumor cells displayed a cell surface and cytoplasmic staining and OcF-binding and uptake occurred in a patchy pattern, indicating that somatostatin receptors were not regularly distributed among tumor cells, as confirmed by ex-vivo immunohistochemistry. Conclusion: CMM with fluorescein labeled octreotate allows real time in-vivo molecular, functional and morphological imaging of sstr-expressing cell structures and, since it is applicable to humans, will permit specific molecular imaging of sstr during ongoing gastrointestinal endoscopy.